These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 229707)

  • 1. Comparative clinical study of FOY and Trasylol in acute pancreatitis.
    Tanaka N; Tsuchiya R; Ishii K
    Adv Exp Med Biol; 1979; 120B():367-78. PubMed ID: 229707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
    Freise J
    Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled trial of protease inhibitor gabexelate mesilate (FOY) in the treatment of acute pancreatitis.
    Yang CY; Chang-Chien CS; Liaw YF
    Pancreas; 1987; 2(6):698-700. PubMed ID: 3125546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients].
    Freise J; Melzer P; Schmidt FW; Horbach L
    Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind controlled clinical trial of Trasylol. Preliminary results in acute pancreatitis and in prophylaxis against postoperative pancreatitis.
    Baden H; Jordal K; Lund F; Zachariae F
    Acta Chir Scand Suppl; 1967; 378():97-102. PubMed ID: 4866570
    [No Abstract]   [Full Text] [Related]  

  • 6. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
    Freise J; Schmidt FW; Magerstedt P; Schmid K
    Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Trasylol treatment of acute pancreatitis. A double-blind study].
    Storck G; Persson B
    Nord Med; 1968 May; 79(20):651-3. PubMed ID: 4872515
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of acute pancreatitis with and without proteinase inhibitor. Comparative clinical studies with Trasylol].
    Hansen HT; Drube HC; Brüning W; Borm D
    Med Klin; 1966 Aug; 61(32):1254-7. PubMed ID: 4871994
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic and curative action of Trasylol in pancreatitis. A double-blind trial.
    Baden H; Jordal K; Lund F; Zachariae F
    Scand J Gastroenterol; 1969; 4(3):291-5. PubMed ID: 4899636
    [No Abstract]   [Full Text] [Related]  

  • 10. Death from acute pancreatitis. M.R.C. multicentre trial of glucagon and aprotinin.
    Lancet; 1977 Sep; 2(8039):632-5. PubMed ID: 71449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter double-blind trial of gabexate mesylate (FOY) in unselected patients with acute pancreatitis.
    Valderrama R; Pérez-Mateo M; Navarro S; Vázquez N; Sanjosé L; Adrián MJ; Estruch J
    Digestion; 1992; 51(2):65-70. PubMed ID: 1499875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of [ethyl p-(6-guanidinohexanoyloxy)benzoate] methanesulfonate (FOY) on kinin formation and fibrinolysis activity].
    Aishita H; Okegawa T; Akimoto A; Makita T; Shimizu H
    Nihon Yakurigaku Zasshi; 1975 Jan; 71(1):89-99. PubMed ID: 169189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single-centre double-blind trial of Trasylol therapy in primary acute pancreatitis.
    Imrie CW; Benjamin IS; Ferguson JC; McKay AJ; Mackenzie I; O'Neill J; Blumgart LH
    Br J Surg; 1978 May; 65(5):337-41. PubMed ID: 348250
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial with Trasylol against acute pancreatitis].
    Möller C; Stjernvall L
    Ann Chir Gynaecol Fenn; 1969; 58(4):296-9. PubMed ID: 4908936
    [No Abstract]   [Full Text] [Related]  

  • 15. Esterase inhibitors prevent lysosomal enzyme redistribution in two noninvasive models of experimental pancreatitis.
    Ohshio G; Saluja AK; Leli U; Sengupta A; Steer ML
    Gastroenterology; 1989 Mar; 96(3):853-9. PubMed ID: 2464526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Controlled therapeutic trial of aprotinin and glucagon in acute pancreatitis (author's transl)].
    Gauthier A; Gillet M; Di Costanzo J; Camelot G; Maurin P; Sarles H
    Gastroenterol Clin Biol; 1978 Oct; 2(10):777-84. PubMed ID: 365662
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models.
    Lankisch PG; Pohl U; Göke B; Otto J; Wereszczynska-Siemiatkowska U; Gröne HJ; Rahlf G
    Gastroenterology; 1989 Jan; 96(1):193-9. PubMed ID: 2909420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of gabexate mesilate (FOY) on experimental DIC.
    Isobe J
    Adv Exp Med Biol; 1979; 120B():385-94. PubMed ID: 229708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of trasylol in the treatment of acute pancreatitis].
    Haberland GL
    Med Welt; 1974 Dec; 25(50):2112-7. PubMed ID: 4548482
    [No Abstract]   [Full Text] [Related]  

  • 20. Gabexate mesilate in the treatment of acute pancreatitis.
    Pederzoli P; Bassi C; Falconi M; De Santis L; Uomo G; Rabitti PG; Talamini G; Cavallini G
    Ann Ital Chir; 1995; 66(2):191-5. PubMed ID: 7545361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.